Menu Back toSession-9-Track-2-Automation-Technologies-in-Medical-Writing
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Medical Affairs and Scientific Communications Forum
Session 9 Track 2: Automation Technologies in Medical Writing
Ruggero Galici, PhD
- Director, Nonclinical and Clinical Pharmacology Writing
- Alexion Pharmaceuticals, AstraZeneca Rare Disease, United States
Automation technologies, especially when combined with artificial intelligence, are disrupting many sectors including the healthcare. This session will explore challenges and opportunities of automation technologies in medical writing. Few examples of how companies and the FDA are using or plan to use automation technologies to improve efficiencies will be discussed.
Learning Objective : At the conclusion of this session, participants should be able to:
- Identify potential automation technologies in medical writing
- Recognize challenges and opportunities when implementing automation technologies in medical writing
Automation and AI in Medical Writing: Pie in the Sky or a Paradigm Shift?
Sian Ratcliffe, PhD
- Vice President, Head of Medical Writing
- Pfizer Inc, United States
AI in the Medical Writing Landscape – Tales from a Pilot Project
Julia Forjanic-Klapproth, PhD
- Senior Partner/President
- Trilogy Writing & Consulting, Germany
Digitizing Decision Documentation at the FDA – Are We There Yet?
Eileen E. Navarro Almario, MD, MS, FACP
- Lead Medical Officer, OCS, OTS, CDER
- FDA, United States
Check out our 2019 Program!